MDLZ monthly performance report
Explore MDLZ's monthly returns, drawdown, and seasonality trends — updated every month.
MDLZ monthly report
—
Key takeaways
- Mondelez International (MDLZ) closed September 2026 at $60.85, down 1.97% for the month and −3.79% over the trailing 12 months.
- Year-to-date, MDLZ is +13.04%, outperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +2.78% versus its 200-day moving average ($59.21), a bullish technical signal.
- Over the past three years, MDLZ has underperformed the S&P 500 by −87.02%, with a relative strength index reading of 49.3.
- Win rate over the trailing 39 months stands at 43.6% — 17 positive months versus 22 negative months.
Mondelez International ended September 2026 at $60.85, posting a monthly return of −1.97%. The S&P 500 returned −0.70% over the same window, leaving relative performance at −1.27%.
The current quarter stands at +5.20% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +2.78% versus the 200-day moving average ($59.21).
Year-to-date, MDLZ is +13.04% against SPY +11.70%, a gap of +1.34%. The stock is currently −8.70% below its 52-week high, with maximum 3-year drawdown at −32.99%.
| Period | MDLZ | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −1.92% | −0.12% | −1.80% |
| 1 Week | −2.55% | −0.34% | −2.21% |
| 1 Month | −1.97% | −0.70% | −1.27% |
| 3 Months | −3.40% | +2.80% | −6.20% |
| 6 Months | +9.92% | +13.85% | −3.93% |
| YTD | +13.04% | +11.70% | +1.34% |
| 12 Months | −3.79% | +15.01% | −18.81% |
| 3 Years | −15.32% | +71.69% | −87.02% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2025 | +10.76% |
| #2 | Jan 2026 | +8.62% |
| #3 | Jul 2026 | +7.73% |
| #4 | Nov 2023 | +7.33% |
| #5 | Apr 2026 | +6.59% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2024 | −8.04% |
| #2 | Oct 2025 | −8.02% |
| #3 | Oct 2024 | −7.04% |
| #4 | Dec 2025 | −6.50% |
| #5 | Mar 2026 | −6.40% |
| Quarter | Return |
|---|---|
| Q2 2025 | −0.60% |
| Q3 2025 | −7.37% |
| Q4 2025 | −13.83% |
| Q1 2026 | +7.08% |
| Q2 2026 | +0.35% |
| Q3 2026 (QTD) | +5.20% |
| Year | Return |
|---|---|
| 2023 | +8.67% |
| 2024 | −17.53% |
| 2025 | −9.88% |
| 2026 | +13.04% |
| Metric | Value |
|---|---|
| 52-Week High | $66.65 (2026-07-29) |
| 52-Week Low | $51.20 (2026-01-08) |
| Current Price | $60.85 |
| 200-Day Moving Average | $59.21 |
| Price vs 200DMA | +2.78% |
| 3-Year Maximum Drawdown | −32.99% (2026-01-07) |
| Current Drawdown from 52W High | −8.70% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 49.3 |
| 3-Year Excess Return vs S&P 500 | −87.02% |
| RS Peak | 102.3 (Sep 2023) |
| RS Trough | 46.1 (Jan 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MDLZ's return for this report period?
MDLZ returned −1.97% in the latest monthly window ending 2026-09-18.
Has MDLZ outperformed SPY year to date?
YTD MDLZ: +13.04% vs SPY: +11.70%.
What is MDLZ's 12-month return?
−3.79% over the trailing 12 months.
Is MDLZ above or below its 200-day moving average?
Price is +2.78% versus 200DMA ($59.21).
What is the maximum drawdown in the 3-year window?
−32.99% on 2026-01-07.